MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1182/blood-2013-04-497040

Медицинская библиотека · Blood · 2014

BCR-ABL1 promotes leukemia by converting p27 into a cytoplasmic oncoprotein.

Agarwal Anupriya, Mackenzie Ryan J, Besson Arnaud, Jeng Sophia, Carey Alyssa, LaTocha Dorian H, Fleischman Angela G, Duquesnes Nicolas, Eide Christopher A, Vasudevan Kavin B, Loriaux Marc M, Firpo Eduardo, Cortes Jorge E, McWeeney Shannon, O'Hare Thomas, Roberts James M, Druker Brian J, Deininger Michael W

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

Recent studies have revealed that p27, a nuclear cyclin-dependent kinase (Cdk) inhibitor and tumor suppressor, can acquire oncogenic activities upon mislocalization to the cytoplasm. To understand how these antagonistic activities influence oncogenesis, we dissected the nuclear and cytoplasmic functions of p27 in chronic myeloid leukemia (CML), a well-characterized malignancy caused by the BCR-ABL1 tyrosine kinase. p27 is predominantly cytoplasmic in CML and nuclear in normal cells. BCR-ABL1 regulates nuclear and cytoplasmic p27 abundance by kinase-dependent and -independent mechanisms, respectively. p27 knockdown in CML cell lines with predominantly cytoplasmic p27 induces apoptosis, consistent with a leukemogenic role of cytoplasmic p27. Accordingly, a p27 mutant (p27(CK-)) devoid of Cdk inhibitory nuclear functions enhances leukemogenesis in a murine CML model compared with complete absence of p27. In contrast, p27 mutations that enhance its stability (p27(T187A)) or nuclear retention (p27(S10A)) attenuate leukemogenesis over wild-type p27, validating the tumor-suppressor function of nuclear p27 in CML. We conclude that BCR-ABL1 kinase-dependent and -independent mechanisms convert p27 from a nuclear tumor suppressor to a cytoplasmic oncogene. These findings suggest that cytoplasmic mislocalization of p27 despite BCR-ABL1 inhibition by tyrosine kinase inhibitors may contribute to drug resistance, and effective therapeutic strategies to stabilize nuclear p27 must also prevent cytoplasmic mislocalization.

Для цитирования: Agarwal Anupriya, Mackenzie Ryan J, Besson Arnaud, Jeng Sophia, Carey Alyssa, LaTocha Dorian H, Fleischman Angela G, Duquesnes Nicolas, Eide Christopher A, Vasudevan Kavin B, Loriaux Marc M, Firpo Eduardo, Cortes Jorge E, McWeeney Shannon, O'Hare Thomas, Roberts James M, Druker Brian J, Deininger Michael W. BCR-ABL1 promotes leukemia by converting p27 into a cytoplasmic oncoprotein.. Blood. 2014. DOI: 10.1182/blood-2013-04-497040.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.